A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of intrarectal Amifostine administration
on acute radiation-induced rectal toxicity in pre-operative chemo-radiotherapy.